Decoquinate-based Products Market:
Overview
Decoquinate
(ethyl 6-decoxy-7-ethoxy-4-oxo-1H-quinoline-3-carboxylate) is an antiprotozoal
agent. It acts against coccidia parasites and is thus known as a coccidiostat. Decoquinate-based
products are majorly used in veterinary medicine. Decoquinate acts on the
sporozoite stage of a coccidian parasite’s lifecycle. The sporozoite can
penetrate the host’s intestinal call and prevents their further development,
which necessitates the use of antiprotozoal substances. Decoquinate has low
toxicity and is administered orally to a wide range of mammalian and avian
species.
Request Brochure –
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11798
Various studies conducted on decoquinate-based products suggest
that the drug is readily tolerated by several target species, including cattle
and lambs. On the other hand, studies conducted on rats and dogs showed minor
changes in food consumption, feed conversion, subdued behavior, and changes in
body weight and organ weight. In conclusion, though there may be a minor risk
posed by decoquinate-based products, the protection it provides against coccidian
parasites comfortably outweighs it.
Decoquinate-based Products Market: Segmentation
The market
for decoquinate-based products can be segmented according to the type of
formulation into powder, tablet, and nanoparticles. Powdered decoquinate dominates
the global decoquinate-based products market owing to its ease of usage.
Powdered decoquinate-based products can easily be added to animal feed, which
also helps the drug get absorbed into the animal’s body at a rapid rate.
Request COVID Analysis on Decoquinate based Products Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=11798
However, nanoscale decoquinate-based products comprise the
fastest growing segment of the global decoquinate-based products market due to
the added advantages nanoparticles provide over powders. The smaller size of
nanoparticles means they can be absorbed into the animal’s body even quicker
than powders. The increased overall surface area of nanoscale decoquinate-based
products also means they are more reactive and more likely to encounter a
coccidian parasite.
According
to a study conducted on mice at the Walter Reed Army Institute of Research in
Silver Springs, MD, U.S., oral administration of nanoscale decoquinate-based
products to mice effectively repressed liver-stage parasite growth, providing
causal prophylaxis. Nanoscale decoquinate-based products were observed to be 15
times more efficacious than microscale decoquinate, which is used in powder and
tablet formulations.
Moreover,
the dosage provided to mice – 1.25 mg/kg – was also much lower than the dosage
provided through powder and tablets – around 20 mg/kg. Thus, nanoscale decoquinate-based
products have been shown to be safer as well as more effective than microscale
products, although the preliminary research in this field needs to be expanded
to draw a definitive conclusion.
Request Customization on Decoquinate based Products Market Report
–
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=11798
Decoquinate-based Products Market:
Regional Outlook
Geographically,
the decoquinate-based products market has been classified into four segments:
North America, Europe, Asia Pacific and Rest of the World. North America and
Europe currently dominate the global decoquinate-based products market due to
the strong economic conditions and the large population of cattle in these
regions. The Europe market for decoquinate-based products is driven by the
rising demand from Switzerland, which is known for its large dairy industry. In
2010, there were 1,591,233 cattle in Switzerland.
Additionally,
several governments in North America and Europe have also set up regulatory
agencies, which have also been instrumental in the growth of the global
decoquinate-based products market. These government bodies provide funds for
developing novel veterinary biologics and animal health products such as
antibodies, vaccines, diagnostic kits, which are used for the prevention,
diagnosis, and treatment of infectious diseases in animals.
The Asia
Pacific market for decoquinate-based products is also growing rapidly due to
the increasing awareness about the benefits of decoquinate among cattle and
poultry breeders.
Pre Book Decoquinate based Products Market Report –
https://www.transparencymarketresearch.com/checkout.php?rep_id=11798<ype=S
Decoquinate-based Products Market: Key
Players
Many major
pharmaceutical companies are involved in the manufacture of decoquinate-based
products. Alpharma, a subsidiary of Pfizer Inc., is a major player in the
global market. The company offers deccox, 3 nitro, Albac, ChlorMax, lincomycin,
and many other decoquinate formulations. Other major brands in the global
decoquinate-based products market include Laboratories Biové’s acti decocci and
lacto decocci, Pharmacia & Upjohn Company’s Lincomix, Sogeval Laboratories’
Rumicox, and Qualian’s Ucamix V decoquinate.
The
research report presents a comprehensive assessment of the market and contains
reliable insights, facts, historical data, and statistically supported and
industry-validated market data. It also contains projections made using a
suitable set of assumptions and methodologies.
About
Us
Transparency
Market Research is a global market intelligence company, providing global
business information reports and services. Our exclusive blend of quantitative
forecasting and trends analysis provides forward-looking insight for thousands
of decision makers. Our experienced team of analysts, researchers, and
consultants, uses proprietary data sources and various tools and techniques to
gather and analyze information.
Our
data repository is continuously updated and revised by a team of research
experts, so that it always reflects the latest trends and information. With a
broad research and analysis capability, Transparency Market Research employs
rigorous primary and secondary research techniques in developing distinctive
data sets and research material for business reports.
Contact
Transparency
Market Research,
90
State Street, Suite 700,
Albany,
NY 12207
Tel:
+1-518-618-1030
USA
- Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
